相关实验视频

Updated: Jan 12, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

肺移植中的监管性T细胞疗法:弥合从长椅到床边的差距

Qianwei Li^1,2, Guorui Li^1,2, Jinteng Feng^1,2

¹Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Frontiers in immunology

|November 7, 2025

概括

调控性T细胞 (Treg) 疗法在改善肺移植结果方面显示出有前途. 了解肺部独特的免疫环境是为移植受体开发有效的Treg治疗的关键.

科学领域:

免疫学免疫学免疫学
移植科学移植科学
细胞疗法细胞疗法

背景情况:

肺移植接受者比其他固体器官移植接受者有较差的结果.
目前的免疫抑制在改善肺移植存活率方面存在局限性.
调节性T细胞 (Tregs) 对于免疫调节至关重要.

研究的目的:

审查Tregs在肺异位移植免疫,排斥和耐受性中的作用.
评估肺移植中的临床前Treg疗法研究.
评估和肝移植的临床Treg经验,以深入了解肺移植.

主要方法:

对肺移植中临床前Treg研究的文献综述.
从脏和肝脏移植试验中分析临床Treg治疗数据.
在肺部全移植中检查Treg机制.

主要成果:

Tregs在肺部全移植免疫反应中发挥着重要作用.
临床前数据表明Treg治疗在肺移植中的潜力.
其他器官的临床试验表明Treg治疗的安全性和降低免疫抑制的潜力.

结论:

对肺移植接受者来说,Treg疗法是一个有前途的策略.
需要进一步的研究来优化Treg疗法用于肺移植.
基于Treg的定制治疗对于改善肺移植结果至关重要.

关键词:

支气管炎消灭症综合征支气管炎消灭症综合征细胞疗法是细胞疗法.慢性肺部异位移植功能障碍慢性肺部异位移植功能障碍免疫耐受性免疫耐受性肺部移植肺部移植监管T细胞的监管性T细胞

更多相关视频

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.